Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.
Clinical trial NCT04900337 · COMPLETED
Trial details
- NCT number
- NCT04900337
- Sponsor
- Amorphical Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-09
- Primary completion
- 2023-06-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.